InvestorsHub Logo
Followers 791
Posts 33694
Boards Moderated 5
Alias Born 01/09/2001

Re: ProfitChaser post# 73918

Tuesday, 03/18/2014 7:55:50 PM

Tuesday, March 18, 2014 7:55:50 PM

Post# of 91547
FWDG may do a BOOM move tomorrow. Nice news out today and I dont even see it on IHUB.

FutureWorld $FWDG HempTech to Create HempTechRX with Advisory Board for CBD-based Pharmaceuticals & Nutraceuticals
CBD-Rich Hemp Oil for Wellness & Nutritional Markets
GlobeNewswire
FutureWorld Energy Inc.

St. Petersburg, FL, March 18, 2014 (GLOBE NEWSWIRE) -- FutureWorld (OTCQB: FWDG), a U.S. Diversified Holding Company formed to capitalize on the burgeoning technology markets globally, announces today that it has created an advisory board for a new planned division called HempTechRX. The new division will concentrate on Cannabidiol (CBD) -based Pharmaceutical & Nutraceutical products for the wellness and nutritional supplement industry.

We believe the industrial hemp oil-based Cannabidiol (CBD) nutritional supplement, wellness and personal care products will become one of the biggest markets nationally. The global Nutraceutical market is projected to be in excess of $200 billion by 2015 and the current US Nutraceutical and Dietary supplement market is valued at around $42 billion. The infusion of the Cannabidiol (CBD) based products into this massive marketplace will create significant opportunities for legal marijuana and hemp based companies (and their shareholders) for the foreseeable future. HempTech through HempTechRX is engaging to be part of this significant opportunity.

Cannabinoids (non-psychoactive CBD) have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of a wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and auto-immune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's, Parkinson's and HIV dementia.

HempTechRX's formation of an advisory board will establish an operational, industry standard, division for Pharmaceutical & Nutraceutical grade products for the wellness and nutritional markets. HempTechRX's management team, through its association with PharmaX, will have extensive access to all the necessary information and resources to provide a sustainable and profitable pharmaceutical-grade division of HempTech.
.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.